Artículos del autor

Dr. Juan Manuel Pérez

Aorta

Conservative management of endoleaks in complex aortic endografts under CT angiography follow-up

Endoleaks remain one of the leading causes of reintervention after endovascular repair of complex aortic aneurysms using...
Dr. Juan Manuel Pérez -
Structural heart disease

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance...
Dr. Juan Manuel Pérez -
Coronary disease

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which...
Dr. Juan Manuel Pérez -
Coronary disease

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with...
Dr. Juan Manuel Pérez -
Femoropopliteal

Is upper-limb aerobic training an effective alternative to lower-limb exercise in peripheral artery disease?

Peripheral artery disease is associated with impaired functional capacity, reduced walking distance, and poorer quality of life,...
Dr. Juan Manuel Pérez -
Chronic Ischemic cardiopathy

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities...
Dr. Juan Manuel Pérez -
Aorta

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using...
Dr. Juan Manuel Pérez -
Pharmacology

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block...
Dr. Juan Manuel Pérez -